Ruth Owen

Ruth Owen

Auto-generated profile, based on publicly available information

Ruth Owen

Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle Upon Tyne, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
AMAbdullah K. Malik
Abdullah K. Malik
STSamuel J. Tingle
Samuel J. Tingle
NCNicholas Chung
Nicholas Chung
RORuth Owen
Ruth Owen
BMBalaji Mahendran
Balaji Mahendran
SWSteven A. White
Steven A. White
Time to arrest in donors after circulatory death is unpredictable and can vary. This leads to variable periods of warm ischaemic damage prior to pancreas transplantation. There is little evidence supporting procurement team stand-down times based on donor time to death (TTD). We examined what impact TTD had on pancreas graft outcomes following DCD SPK transplantation. Data were extracted from the UK transplant registry from 2014 to 2022. Predictors of graft loss were evaluated by a Cox proportional hazards model. Adjusted restricted cubic spline (RCS) models were generated to further delineate the relationship between TTD and outcome. Three-hundred-and-seventy-five DCD simultaneous kidney-pancreas transplant recipients were included. Increasing TTD was not associated with graft survival (aHR 0.98, 95% CI 0.68-1.41, P=0.901). Increasing asystolic time worsened graft survival (aHR 2.51, 95% CI 1.16-5.43, P=0.020). RCS modelling revealed a non-linear relationship was demonstrated between asystolic time and graft survival, and no relationship between TTD and graft survival. We found no evidence that TTD impacts on pancreas graft survival after DCD SPK transplantation, however increasing asystolic time was a significant predictor of graft loss. Procurement teams should attempt to minimise asystolic time to optimize pancreas graft survival rather than focus on the duration of TTD.

14 February 2026 in HPB
Verified
Journal Article
Open access
VPVivek Peddakota
Vivek Peddakota
RORuth Owen
Ruth Owen
NJNejo Joseph
Nejo Joseph
LMLitesh Chouhan Mudavath
Litesh Chouhan Mudavath
CKCecilie Siggaard Knoph
Cecilie Siggaard Knoph
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana
This systematic review aims to identify the core outcome domains and assessment methods currently used in randomised controlled trials (RCTs) for acute postoperative pain following pancreatic surgery. PubMed, Embase, Web of Science, and the Cochrane Library were searched without restrictions. Eligible studies were screened and data extracted for pain assessment tools, analgesic outcomes, adverse effects, pain interference and quality-of-life measures. Fifteen RCTs involving 1034 patients were included. All trials assessed pain intensity using a visual analogue scale (n = 11) or a numerical rating scale (n = 4). Analgesic consumption was reported in 13 trials, with significant variability in the reporting, rescue analgesia and adverse effects. Pain interference or physical function was described in 10 trials, including pain on coughing (n = 4), mobilisation (n = 3), % gait speed and % peak cough flow (n = 2). Multidimensional tools were rarely used, with a single RCT employing three different scales. Psychological function was assessed in one trial using anxiety and depression scales. There was notable heterogeneity in pain domains assessed and the tools used across pain management RCTs post-pancreatectomy. This highlights the need for standardized core outcome domains and multidimensional tools specific to pancreatic surgery to enable comparability of data and robust analysis.